Logo image of STAB

STATERA BIOPHARMA INC (STAB) Stock Analyst Earnings Estimates

NASDAQ:STAB - Nasdaq - US8575611046 - Common Stock - Currency: USD

0.0911  -0.01 (-5.2%)

After market: 0.0918 +0 (+0.77%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021
Revenue
YoY % growth
STAB revenue by date.STAB revenue by date.
1.113M
-2.18%		262.94K
-76.38%		1.487M
465.54%
EBITDA
YoY % growth
STAB ebitda by date.STAB ebitda by date.
-2.347M
50.92%		-2.575M
-9.72%		-29.687M
-1,052.86%
EBIT
YoY % growth
STAB ebit by date.STAB ebit by date.
-2.361M
50.81%		-2.587M
-9.56%		-29.943M
-1,057.64%
Operating Margin
STAB operating margin by date.STAB operating margin by date.
-212.03%-983.70%-2,013.59%
EPS
YoY % growth
STAB eps by date.STAB eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
STAB Yearly EPS VS EstimatesSTAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 0.1 0.2 0.3 0.4 0.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 670.47K
183.47%		%
Q3 2021
Q2Q % growth		 236.52K
441.86%		%
Q2 2021
Q2Q % growth
-100.00%		%
STAB Yearly Revenue VS EstimatesSTAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A